KATHLEEN FLAHERTY: Open Payments
NPI 1265755565 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 25 payments from 9 companies in 2025. Trend: 2023 $1,439 · 2024 $238 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $237 |
| Lilly USA, LLC | 2 | $40 |
| PFIZER INC. | 1 | $30 |
| ARGENX US, INC. | 1 | $28 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $27 |
| Biogen, Inc. | 1 | $27 |
| EMD Serono, Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
Products named: QULIPTA, NURTEC ODT, VYVGART HYTRULO, FYCOMPA, LEQEMBI, KISUNLA, AMYVID, NUPLAZID.
Industry payments across GA — which companies pay providers there.
